☆ 4.3 Review

From Developing Guidelines to Implementing Legislation: Actions of the US Advisory Committee on Heritable Disorders in Newborns and Children Toward Advancing and Improving Newborn Screening

SEMINARS IN PERINATOLOGY (2010)

期刊

SEMINARS IN PERINATOLOGY

卷 34, 期 2, 页码 121-124

出版社

W B SAUNDERS CO-ELSEVIER INC

DOI: 10.1053/j.semperi.2009.12.004

关键词

newborn screening; policy development; rare disorders

类别

Obstetrics & Gynecology Pediatrics

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Neurosciences

The future of newborn screening for lysosomal disorders

Melissa P. Wasserstein, Joseph J. Orsini, Aaron Goldenberg, Michele Caggana, Paul A. Levy, Margo Breilyn, Michael H. Gelb

Summary: The goal of newborn screening is to detect serious and treatable disorders early to improve patient outcomes. Lysosomal storage disorders (LSDs), a group of over 50 diseases, are being increasingly screened in newborns with the aim of reducing disease morbidity and mortality through early detection using a variety of methods including enzyme replacement therapies and gene therapies.

NEUROSCIENCE LETTERS (2021)

添加到收藏夹

Review Genetics & Heredity

Genomic newborn screening for rare diseases

Zornitza Stark, Richard H. Scott

Summary: Rare diseases are a significant cause of infant mortality and lifelong disability. Genomic sequencing has revolutionized diagnosis and offers the potential to greatly expand the early detection of treatable rare diseases through newborn screening programs. This review discusses the challenges and opportunities associated with incorporating genomic sequencing into newborn screening, including the need for evidence of benefit and addressing ethical and psychosocial concerns. The authors summarize the current evidence and identify key research priorities.

NATURE REVIEWS GENETICS (2023)

添加到收藏夹

Review Medical Laboratory Technology

Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies

Yolanda Gonzalez-Irazabal, Guillermo Hernandez de Abajo, Eduardo Martinez-Morillo

Summary: Newborn screening programs have been proven to be effective in detecting diseases early and allowing for early intervention to prevent adverse outcomes. However, different countries and regions have adopted diverse strategies and diagnostic algorithms in their NBS programs, leading to discrepancies in detection opportunities. Despite efforts to harmonize NBS programs internationally, there are still significant differences that need to be addressed.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2021)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Newborn screening system: Safety, technology, advocacy

Edward R. B. McCabe

Summary: Newborn screening has a history of over 50 years and should be viewed as a complete system rather than just a test. Improving safety culture and reducing the risk of missed screenings requires a community effort, and cannot solely rely on new technologies. It is important to focus on biomarkers rather than being solely seduced by genomic sequencing technology.

MOLECULAR GENETICS AND METABOLISM (2021)

添加到收藏夹

Article Pediatrics

Preparing newborn screening for the future: a collaborative stakeholder engagement exploring challenges and opportunities to modernizing the newborn screening system

Sara M. Andrews, Katherine Ackerman Porter, Donald B. Bailey, Holly L. Peay

Summary: This study aims to assess and address the challenges facing the newborn screening (NBS) system in the United States and propose modernization solutions. The results from surveys and panel discussions highlight important challenges such as missing data for decision-making, burden on state laboratories, and the time needed for screening new conditions. The discussions emphasize the importance of infant well-being, the impact of transformative therapies on screening capacity, and the need for collaboration in modernization.

BMC PEDIATRICS (2022)

添加到收藏夹

Article Medicine, General & Internal

Target Diseases for Neonatal Screening in Germany Challenges for Treatment and Long-Term Care

Ute Spiekerkoetter, Heiko Krude

Summary: Neonatal screening in Germany detects metabolic diseases early, allowing for better development and a normal life. Approximately one in five newborns have positive screening findings, making prompt evaluation and treatment essential.

DEUTSCHES ARZTEBLATT INTERNATIONAL (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China

Chanjuan Hao, Ruolan Guo, Xuyun Hu, Zhan Qi, Qi Guo, Xuanshi Liu, Yuanhu Liu, Yanhua Sun, Xiaofen Zhang, Feng Jin, Xiujie Wu, Ren Cai, Dingyuan Zeng, Xijiang Hu, Xiaohua Wang, Xiaoping Ji, Wenjie Li, Quansheng Xing, Lanfang Mu, Xiulian Jiang, Xue Yang, Weimin Yang, Yan Zhang, Qianli Yin, Xin Ni, Wei Li

Summary: Different newborn screening programs have been implemented in many countries since the 1960s. This study introduces a new genetic screening method called NESTS, which identified a portion of clinically confirmed monogenic disorder cases through follow-up. The study also reveals regional variations in the disease/gene spectrum in China. NESTS is proven to be feasible and cost-effective as a first-tier newborn screening program, potentially changing the current clinical practice of newborn screening in China.

JOURNAL OF GENETICS AND GENOMICS (2022)

添加到收藏夹

Article Genetics & Heredity

Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population

Xia Li, Jun He, Ling He, Yudong Zeng, Xuzhen Huang, Yechao Luo, Yujiao Li

Summary: This study retrospectively analyzed the results of expanded newborn screening in Changsha and identified 14 types of inherited metabolic disorders. The most common disorders in the region were primary carnitine deficiency, hyperphenylalaninemia, and short-chain acyl-CoA dehydrogenase deficiency. Utilizing tandem mass spectrometry in newborn screening can facilitate early diagnosis and treatment, preventing irreversible growth and intellectual development disorders.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Review Genetics & Heredity

Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America

Roberto Giugliani, Silvia Castillo Taucher, Sylvia Hafez, Joao Bosco Oliveira, Mariana Rico-Restrepo, Paula Rozenfeld, Ignacio Zarante, Claudia Gonzaga-Jauregui

Summary: Rare diseases have significant impacts in Latin America, but there is no consensus on their definition. Diagnostic delays create burdens for patients, caregivers, healthcare systems, and society. This review explores the barriers to implementing newborn screening programs and early diagnostic methods for rare diseases in Latin America, and provides recommendations to address these challenges.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Article Computer Science, Information Systems

Usability testing of the Philippine Electronic National Newborn Hearing Screening Registry (ENNHSR)

Rosario R. Ricalde, Jonathan G. Fabia, Carlos Diego A. Rozul, Maria Rina T. Reyes Quintos, Raymond Francis R. Sarmiento

Summary: The study aimed to assess the usability of the online and offline versions of the Philippine Electronic National Newborn Hearing Screening Registry (ENNHSR) and examine user perspectives and satisfaction with the training modules and system. The study involved the development of the ENNHSR systems, training modules, evaluation of the user manual, and conducting user training sessions. The results showed positive feedback from participants and identified areas for improvement.

INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS (2022)

添加到收藏夹

Article Pediatrics

Case report: Cystic fibrosis with kwashiorkor: A rare presentation in the era of universal newborn screening

Annemarie G. Wolfe, Stephanie P. Gilley, Stephanie W. Waldrop, Christina Olson, Emma Harding, Kaitlin Widmer, Lindsey B. Gumer, Matthew Haemer, Jordana E. Hoppe

Summary: Universal newborn screening has changed the way CF is diagnosed, with nearly all cases being detected shortly after birth. However, clinicians should still be aware of the possibility of CF in newborns with normal screening results.

FRONTIERS IN PEDIATRICS (2023)

添加到收藏夹

Article Genetics & Heredity

Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates

Xinwen Huang, Dingwen Wu, Lin Zhu, Wenjun Wang, Rulai Yang, Jianbin Yang, Qunyan He, Bingquan Zhu, Ying You, Rui Xiao, Zhengyan Zhao

Summary: This study used next-generation sequencing technology to design a newborn genetic sequencing panel and found that it could effectively identify genetic disorders in neonates compared to traditional screening methods. The results of this study lay the foundation for further improvement in the early identification of congenital disorders.

ORPHANET JOURNAL OF RARE DISEASES (2022)

添加到收藏夹

Review Endocrinology & Metabolism

How longitudinal observational studies can guide screening strategy for rare diseases

Ulrike Muetze, Katharina Mengler, Nikolas Boy, Florian Gleich, Thomas Opladen, Sven F. Garbade, Stefan Koelker

Summary: Newborn screening is an important prevention program, but there are still limitations, such as incomplete understanding of the natural history and phenotypic diversity of certain screened diseases, and difficulties in early and precise prediction of individual disease severity. Patient registries can serve as a tool to fill the current knowledge gaps and provide information for further optimization of the strategy.

JOURNAL OF INHERITED METABOLIC DISEASE (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Opportunistic Osteoporosis Screening Using Chest Radiographs With Deep Learning: Development and External Validation With a Cohort Dataset

Miso Jang, Mingyu Kim, Sung Jin Bae, Seung Hun Lee, Jung-Min Koh, Namkug Kim

Summary: This study utilized a deep learning model to achieve osteoporosis screening on chest radiographs, showing promising results. The OsPor-screen model achieved an AUC of 0.91 and 0.88 in the internal and external test sets, respectively.

JOURNAL OF BONE AND MINERAL RESEARCH (2022)

添加到收藏夹

Review Medical Laboratory Technology

Newborn screening of mucopolysaccharidosis type I

Maria Alice Donati, Elisabetta Pasquini, Marco Spada, Giulia Polo, Alberto Burlina

Summary: Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disease caused by a deficiency of alpha-L-iduronidase. Early identification through newborn screening and intervention can prevent irreversible manifestations. Despite some limitations, screening programs have been implemented worldwide, contributing to a favorable risk-benefit ratio and improved disease management.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2022)

添加到收藏夹

Review Obstetrics & Gynecology

Newborn screening for spinal muscular atrophy: Anticipating an imminent need

Han C. Phan, Jennifer L. Taylor, Harry Hannon, Rodney Howell

SEMINARS IN PERINATOLOGY (2015)

添加到收藏夹

Review Pediatrics

Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment

Qing Ke, Zheng-Yan Zhao, Robert Griggs, Veronica Wiley, Anne Connolly, Jennifer Kwon, Ming Qi, Daniel Sheehan, Emma Ciafaloni, R. Rodney Howell, Petra Furu, Peter Sazani, Arvind Narayana, Michele Gatheridge

WORLD JOURNAL OF PEDIATRICS (2017)

添加到收藏夹

Review Genetics & Heredity

From a Single Child to Uniform Newborn Screening: My Lucky Life in Pediatric Medical Genetics

R. Rodney Howell

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 19 (2018)

添加到收藏夹

Editorial Material Genetics & Heredity

MOVR-NeuroMuscular ObserVational Research, a unified data hub for neuromuscular diseases

R. Rodney Howell, Stephan Zuchner

GENETICS IN MEDICINE (2019)

添加到收藏夹

Biographical-Item Genetics & Heredity

Louis J. Skip Elsas II, MD, FACMG IN MEMORIAM

R. Rodney Howell

GENETICS IN MEDICINE (2013)

添加到收藏夹

Article Genetics & Heredity

Including ELSI research questions in newborn screening pilot studies

Aaron J. Goldenberg, Michele Lloyd-Puryear, Jeffrey P. Brosco, Bradford Therrell, Lynn Bush, Susan Berry, Amy Brower, Natasha Bonhomme, Bruce Bowdish, Denise Chrysler, Angus Clarke, Thomas Crawford, Edward Goldman, Sally Hiner, R. Rodney Howell, David Orren, Benjamin S. Wilfond, Michael Watson

GENETICS IN MEDICINE (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Appropriateness of Newborn Screening for α1-Antitrypsin Deficiency

Jeffrey Teckman, Erin Pardee, R. Rodney Howell, David Mannino, Richard R. Sharp, Mark Brantly, Adam Wanner, Jamie Lamson

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism

Kathryn M. Camp, Michele A. Lloyd-Puryear, Lynne Yao, Stephen C. Groft, Melissa A. Parisi, Andrew Mulberg, Rashmi Gopal-Srivastava, Stephen Cederbaum, Gregory M. Enns, Abby G. Ershow, Dianne M. Frazier, John Gohagan, Cary Harding, R. Rodney Howell, Karen Regan, Peter W. Stacpoole, Charles Venditti, Jerry Vockley, Michael Watson, Paul M. Coates

MOLECULAR GENETICS AND METABOLISM (2013)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Fifty years of newborn screening

R. Rodney Howell

MOLECULAR GENETICS AND METABOLISM (2014)

添加到收藏夹

Article Endocrinology & Metabolism

Phenylketonuria Scientific Review Conference: State of the science and future research needs

Kathryn M. Camp, Melissa A. Parisi, Phyllis B. Acosta, Gerard. T. Berry, Deborah A. Bilder, Nenad Blau, Olaf A. Bodamer, Jeffrey P. Brosco, Christine S. Brown, Alberto B. Burlina, Barbara K. Burton, Christine S. Chang, Paul M. Coates, Amy C. Cunningham, Steven F. Dobrowolski, John H. Ferguson, Thomas D. Franklin, Dianne M. Frazier, Dorothy K. Grange, Carol L. Greene, Stephen C. Groft, Cary O. Harding, R. Rodney Howell, Kathleen L. Huntington, Henrietta D. Hyatt-Knorr, Indira P. Jevaji, Harvey L. Levy, Uta Lichter-Konecki, Mary Lou Lindegren, Michele A. Lloyd-Puryear, Kimberlee Matalon, Anita MacDonald, Melissa L. McPheeters, John J. Mitchell, Shideh Mofidi, Kathryn D. Moseley, Christine M. Mueller, Andrew E. Mulberg, Lata S. Nerurkar, Beth N. Ogata, Anne R. Pariser, Suyash Prasad, Gabriella Pridjian, Sonja A. Rasmussen, Uma M. Reddy, Frances J. Rohr, Rani H. Singh, Sandra M. Sirrs, Stephanie E. Stremer, Danilo A. Tagle, Susan M. Thompson, Tiina K. Urv, Jeanine R. Utz, Francjan van Spronsen, Jerry Vockley, Susan E. Waisbren, Linda S. Weglicki, Desiree A. White, Chester B. Whitley, Benjamin S. Wilfond, Steven Yannicelli, Justin M. Young

MOLECULAR GENETICS AND METABOLISM (2014)

添加到收藏夹

Review Pediatrics

Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy

Annemieke Aartsma-Rus, Madhuri Hegde, Tawfeg Ben-Omran, Filippo Buccella, Alessandra Ferlini, Pia Gallano, R. Rodney Howell, France Leturcq, Ann S. Martin, Anna Potulska-Chromik, Jonas A. Saute, Wolfgang M. Schmidt, Thomas Sejersen, Sylvie Tuffery-Giraud, Zehra Oya Uyguner, Luci A. Witcomb, Shu Yau, Stanley F. Nelson

JOURNAL OF PEDIATRICS (2019)

添加到收藏夹

Editorial Material Genetics & Heredity

We must now put in place an updated, comprehensive newborn screening program for deaf and hard-of-hearing infants

R. Rodney Howell

GENETICS IN MEDICINE (2019)

添加到收藏夹

Editorial Material Genetics & Heredity

Whole-genome sequencing holds the key to the success of gene-targeted therapies COMMENT

Jerry Vockley, Annemieke Aartsma-Rus, Jennifer L. Cohen, Lex M. Cowsert, R. Rodney Howell, Timothy W. Yu, Melissa P. Wasserstein, Thomas Defay

Summary: Rare genetic disorders affect a certain percentage of newborn babies, and early diagnosis and treatment are challenging. The advancement of whole-genome sequencing (WGS) technology provides the possibility of early diagnosis and opens up new avenues for the treatment of rare genetic disorders. However, there are still several challenges to overcome. This article summarizes the impact of WGS on the diagnosis and treatment of rare genetic disorders.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2023)

添加到收藏夹

Review Genetics & Heredity

The Progress and Future of US Newborn Screening

Michael S. Watson, Michele A. Lloyd-Puryear, R. Rodney Howell

Summary: Progress in newborn screening has been driven by advancements in science and technology, consumer advocacy, provider actions, and government funding. The current increase in clinical trials for rare diseases has created a need for expansion and improvement. Genome and exome sequencing have provided more opportunities for early identification and prevention, but the challenge lies in screening for rare genetic diseases and the need for extensive population and genomic data. Recommendations include defining screening criteria, financing expansion, establishing infrastructure, and improving communication.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2022)

添加到收藏夹

Meeting Abstract Endocrinology & Metabolism

THE REALPOLITIK OF NEWBORN SCREENING

R. Rodney Howell

MOLECULAR GENETICS AND METABOLISM (2014)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.